Bonjesta

Active Ingredient(s): Doxylamine Succinate + Pyridoxine Hydrochloride
FDA Approved: * November 7, 2016
Pharm Company: * DUCHESNAY
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bonjesta Overview

Doxylamine is a first-generation antihistamine, first reported in 1949.[3][4] It can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief. Doxylamine is also used in combination with the analgesics paracetamol (acetaminophen) and codeine as an analgesic/calmative preparation, and is prescribed in combination with vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women. Its fetal safety is “A” in ...

Read more Bonjesta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doxylamine

Recent Bonjesta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doxylamine Succinate + Pyridoxine Hydrochloride
  • Tablet, Extended Release: 20mg + 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (3 results)